Antidiuretic Effect and Pharmacokinetics of Oral 1-Desamino-8-D-Arginine Vasopressin. 1. Studies in Adults and Children
- 1 July 1986
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 63 (1) , 129-132
- https://doi.org/10.1210/jcem-63-1-129
Abstract
The dose-response relationships and pharmacokinetics of orally administeredl-desamino-8-D-AVP (DDAVP) were investigated. In water-loaded normal subjects marked reductions inurine flow rate and increases in urinary osmolality occurred. The responses were maximal 2 h afteringestion of 50, 100, and 200 µg, and lasted at least 6 h. Plasma DDAVP levels increased in a dose-dependent fashion and its disappearance from the plasma followed an exponential time course, witha half-life 86 to 142 min. In water-loaded adults with central diabetes insipidus (CDI), 200 µg oral DDAVP caused marked antidiuresis and mean urinary osmolality increased from 107 mosm/kg to 554mosm/kg after 3 h. In these patients the effect also lasted at least 6 h. Children with CDI were less sensitive than normal subjects to the 50-µg dosage and required 100 µg orally to achieve a duration of action similar to that resulting from 200 µg in adults. Oral DDAVP may be useful for treating some patients with CDI.Keywords
This publication has 6 references indexed in Scilit:
- Sexual Dimorphism in the Posterior Pituitary Response to Stress in the Rat*Endocrinology, 1985
- Plasma concentrations of 1-deamino-8-d-arginine vasopressin after intragastric administration in the ratActa Endocrinologica, 1985
- PERORAL TREATMENT OF DIABETES-INSIPIDUS WITH A POLYPEPTIDE HORMONE ANALOG, DESMOPRESSIN1985
- Antidiuretic effect of perorally administered DDAVP in hydrated humansActa Endocrinologica, 1984
- A model for the study of the oral administration of peptide hormonesCanadian Journal of Biochemistry, 1979
- PHARMACOKINETICS OF 1-DESAMINO-8-D-ARGININE VASOPRESSIN (DDAVP) IN PATIENTS WITH CENTRAL DIABETES INSIPIDUSClinical Endocrinology, 1978